VCA Inc. (NASDAQ:WOOF) Files An 8-K Other Events
Item 8.01 Other Events.

As previously reported, on January 7, 2017, VCA Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with MMI Holdings, Inc., a Delaware corporation (“Acquiror”), Venice Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Acquiror (“Venice Merger Sub”), and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation (“Mars”), providing for the merger of Venice Merger Sub with and into the Company, with the Company continuing as the surviving corporation and a wholly owned subsidiary of Acquiror (the “Merger”). Under the terms of the Merger Agreement, the Merger cannot be completed until the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), has expired or been terminated and the other closing conditions under the Merger Agreement have been satisfied or waived.

The Company and Mars have filed their respective notification and report forms with the Antitrust Division of the U.S. Department of Justice and the Federal Trade Commission (the “FTC”). On April 10, 2017, the Company and Mars received a request from the FTC for additional information and documentary materials (the “Second Request”). The Second Request is a standard part of the regulatory process in connection with the FTC’s review. The Second Request extends the waiting period under the HSR Act until 30 days after the date that the Company and Mars certify substantial compliance with the Second Request, unless the waiting period is extended voluntarily by the parties or terminated earlier by the FTC. The Company continues to anticipate that the Merger will be completed in the third quarter of 2017.

Forward-Looking Statements

This report contains forward-looking statements within the meaning of the securities laws with respect to the proposed transaction between the Company, Mars and certain subsidiaries of Mars. The Company has included herein statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company generally identifies forward-looking statements in this report using words like “believe,” “intend,” “expect,” “estimate,” “may,” “plan,” “should,” “could,” “forecast,” “looking ahead,” “possible,” “will,” “project,” “contemplate,” “anticipate,” “predict,” “potential,” “continue,” or similar expressions. You may find some of these statements below and elsewhere in this report. These forward-looking statements are not historical facts and are inherently uncertain and outside of the Company’s control. Any or all of the Company’s forward-looking statements in this report may turn out to be incorrect. They can be affected by inaccurate assumptions the Company might make, or by known or unknown risks and uncertainties. Many factors mentioned in the Company’s discussion in this report will be important in determining future results. Consequently, no forward-looking statement can be guaranteed. Actual future results may vary materially. Many factors could cause actual future events to differ materially from the forward-looking statements in this report, including but not limited to: (i) the risk that the proposed transaction may not be completed in a timely manner or at all, which may adversely affect the Company’s business and the price of the common stock of the Company; (ii) the failure to satisfy or obtain waivers of the conditions to the consummation of the proposed transaction, including the receipt of certain governmental and regulatory approvals; (iii) the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; (iv) the effect of the announcement or pendency of the proposed transaction on the Company’s business relationships, operating results and business generally; (v) risks that the proposed transaction disrupts current plans and operations of the Company, including the risk of adverse reactions or changes to business relationships with customers, suppliers and other business partners of the Company; (vi) potential difficulties in the hiring or retention of employees of the Company as a result of the proposed transaction; (vii) risks related to diverting management’s attention from the Company’s ongoing business

operations; (viii) potential litigation relating to the Merger Agreement or the proposed transaction; (ix) unexpected costs, charges or expenses resulting from the proposed transaction; (x) competitive responses to the proposed transaction; and (xi) legislative, regulatory and economic developments. The foregoing list of factors is not exclusive. Additional risks and uncertainties that could affect the Company’s financial and operating results are included under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in the Company’s most recent Annual Report on Form 10-K for the year ended December 31, 2016, filed with the Securities and Exchange Commission (the “SEC”) on February 28, 2017, and the Company’s more recent reports filed with the SEC. The Company can give no assurance that the conditions to the proposed transaction will be satisfied, or that it will close within the anticipated time period. Investors and security holders are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which statements were made. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

About VCA Inc. (NASDAQ:WOOF)

VCA Inc. is an animal healthcare company. The Company operates through five segments. Its Animal Hospital segment provides veterinary services for companion animals and sells related retail and pharmaceutical products. Its Laboratory segment provides diagnostic laboratory testing services for veterinarians, both associated with its animal hospitals and those independent of the Company. Its Medical Technology segment sells digital radiography and ultrasound imaging equipment; provides education and training on the use of that equipment; provides consulting and mobile imaging services, and sells software and ancillary services. Its Vetstreet segment provides a range of services to the veterinary community, including online communications, professional education, marketing solutions and a home delivery platform. Its Camp Bow Wow business franchises a premier provider of pet services, including dog day care, overnight boarding, grooming and other ancillary services at pet care facilities.

VCA Inc. (NASDAQ:WOOF) Recent Trading Information

VCA Inc. (NASDAQ:WOOF) closed its last trading session down -0.01 at 91.70 with 727,861 shares trading hands.